Tag: Washington DC

news-09112024-161058

Exploring Trump and RFK Jr.’s Impact on Healthcare: Possibilities and Limitations

Republicans are gearing up to take charge in Washington, with high hopes of turning their healthcare goals into reality. After years of being overshadowed by a Democratic White House and Senate, congressional Republicans and...
reform-the-fda-to-mprove-effectiveness-and-accountability

Reform the FDA to Improve Effectiveness and Accountability

Lee Cooper, a biotechnology investor and ethical bio-innovation instructor, has sounded the alarm on the fragmented nature of the U.S. Food and Drug Agency (FDA). In his recent call for reform, Cooper highlights the...
news-03122024-032802

Supreme Court Case: FDA Regulation of Flavored Vapes Under Scrutiny

Supreme Court Case: FDA Regulation of Flavored Vapes Under ScrutinyThe Supreme Court is currently at the center of a pivotal case that could reshape how the Food and Drug Administration (FDA) oversees flavored vaping...
news-30112024-003624

Former FDA Chief Seeks to Undermine RFK Jr.’s Senate Confirmation

Former FDA Chief Expresses Concerns Over RFK Jr.'s Senate ConfirmationIn a recent television appearance, Scott Gottlieb, the former commissioner of the Food and Drug Administration under the Trump administration, has raised red flags with...
news-20112024-002106

Dr. Oz appointed by Trump to head Medicare and Medicaid

President-elect Trump has chosen Dr. Mehmet Oz, a well-known surgeon and television personality, to lead the Centers for Medicare and Medicaid Services. This agency plays a crucial role in setting policies that affect payments...
news-17112024-121227

RFK Jr.’s Potential Impact on Vaccine Maker Legal Protections as HHS Secretary

Robert F. Kennedy Jr., President-elect Trump's pick for secretary of Health and Human Services, is not a fan of laws that protect vaccine manufacturers from lawsuits. If he assumes the position, he could potentially...
news-07112024-155051

Biotech Outlook Post-Trump Presidency: What’s Next?

Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...